Sign in

CIK 0001999480

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Alto Neuroscience, Inc.

Sign in to watch
Ticker
ANRO
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
834210124
Phone
+1 773-255-5012
Business address
650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, CA, 94041
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,567,247
in 1 filing

Net −$3,567,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Smith Nicholas Conrad −$3.6M PRESIDENT AND CFO sold 85% of stake
Date Insider Transaction Shares Price Value Owned after
2026-05-12 York Gwill Director Grant or award · Stock Option (right to buy) +10,958 10,958
2026-01-02 York Gwill Director Grant or award · Stock Option (right to buy) +5,243 $11.82 $62K 5,243
2025-05-13 York Gwill Director Grant or award · Stock Option (right to buy) +15,287 15,287
2025-01-02 York Gwill Director Grant or award · Stock Option (right to buy) +19,558 $3.17 $62K 19,558
2024-02-06 York Gwill Director Conversion +23,917 23,917
2024-02-06 York Gwill Director Conversion · Series A Preferred Stock −53,196 0
2024-02-01 York Gwill Director Grant or award · Stock Option (right to buy) +30,574 30,574
2024-02-01 York Gwill Director Grant or award · Stock Option (right to buy) +3,083 $11.88 $37K 3,083

Page 1 of 1 · 8 trades